Although the exact mechanism of mTOR-inhibitor-associated PAP is unclear, an association between this drug class and development of PAP likely exists, as our case is the seventh report of this complication in solid organ transplant recipients treated with mTOR-inhibitors. Here, MTOR is linked to pulmonary alveolar proteinosis.